Eli Lilly Singapore Pte Ltd
Pharma Innovator for Chronic Disease
Eli Lilly Singapore Pte Ltd is the Singapore arm of the American pharmaceutical company known for insulin, psychiatric medicines, and weight management treatments. Eli Lilly Singapore Pte Ltd manages Singapore’s commercial operations for Mounjaro tirzepatide, Trulicity dulaglutide diabetes medicines, Verzenio breast cancer treatment, and Olumiant rheumatoid arthritis biologic. Singapore’s growing obesity and diabetes burden makes Eli Lilly’s GLP-1 receptor agonist portfolio particularly relevan.
Address & Contact
- +65 6100 9900
- enquiry.sg@lilly.com
- www.lilly.com.sg